nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA2—periosteum—sarcoma	0.02	0.11	CbGeAlD
Brinzolamide—CA5B—mammary gland—sarcoma	0.0104	0.0572	CbGeAlD
Brinzolamide—CA14—seminal vesicle—sarcoma	0.00951	0.0524	CbGeAlD
Brinzolamide—CA5A—liver—sarcoma	0.00845	0.0466	CbGeAlD
Brinzolamide—CA14—cardiac atrium—sarcoma	0.00686	0.0378	CbGeAlD
Brinzolamide—CA12—connective tissue—sarcoma	0.00679	0.0374	CbGeAlD
Brinzolamide—CA5B—hematopoietic system—sarcoma	0.00632	0.0348	CbGeAlD
Brinzolamide—CA9—tendon—sarcoma	0.00631	0.0347	CbGeAlD
Brinzolamide—CA14—tendon—sarcoma	0.00598	0.033	CbGeAlD
Brinzolamide—CA1—hematopoietic system—sarcoma	0.00558	0.0308	CbGeAlD
Brinzolamide—CA9—testis—sarcoma	0.00522	0.0288	CbGeAlD
Brinzolamide—CA5B—cardiac atrium—sarcoma	0.0048	0.0264	CbGeAlD
Brinzolamide—CA14—liver—sarcoma	0.00468	0.0258	CbGeAlD
Brinzolamide—CA4—seminal vesicle—sarcoma	0.00459	0.0253	CbGeAlD
Brinzolamide—CA5B—tendon—sarcoma	0.00418	0.0231	CbGeAlD
Brinzolamide—CA2—embryo—sarcoma	0.00405	0.0223	CbGeAlD
Brinzolamide—CA1—lymphoid tissue—sarcoma	0.00393	0.0217	CbGeAlD
Brinzolamide—CA2—seminal vesicle—sarcoma	0.00381	0.021	CbGeAlD
Brinzolamide—CA2—hematopoietic system—sarcoma	0.00362	0.0199	CbGeAlD
Brinzolamide—CA1—bone marrow—sarcoma	0.00358	0.0197	CbGeAlD
Brinzolamide—CA2—connective tissue—sarcoma	0.00348	0.0192	CbGeAlD
Brinzolamide—CA5B—testis—sarcoma	0.00346	0.0191	CbGeAlD
Brinzolamide—CA4—cardiac atrium—sarcoma	0.00331	0.0183	CbGeAlD
Brinzolamide—CA2—smooth muscle tissue—sarcoma	0.00319	0.0176	CbGeAlD
Brinzolamide—CA2—skin of body—sarcoma	0.00315	0.0173	CbGeAlD
Brinzolamide—CA1—liver—sarcoma	0.00289	0.0159	CbGeAlD
Brinzolamide—CA4—tendon—sarcoma	0.00289	0.0159	CbGeAlD
Brinzolamide—CA4—bone marrow—sarcoma	0.0028	0.0154	CbGeAlD
Brinzolamide—CA2—cardiac atrium—sarcoma	0.00275	0.0151	CbGeAlD
Brinzolamide—CA2—lymphoid tissue—sarcoma	0.00255	0.014	CbGeAlD
Brinzolamide—CA5B—lymph node—sarcoma	0.00251	0.0138	CbGeAlD
Brinzolamide—CA2—tendon—sarcoma	0.00239	0.0132	CbGeAlD
Brinzolamide—CA4—testis—sarcoma	0.00239	0.0132	CbGeAlD
Brinzolamide—CYP3A4—hematopoietic system—sarcoma	0.00233	0.0129	CbGeAlD
Brinzolamide—CA2—bone marrow—sarcoma	0.00232	0.0128	CbGeAlD
Brinzolamide—Diplopia—Epirubicin—sarcoma	0.00226	0.00276	CcSEcCtD
Brinzolamide—Pain in extremity—Epirubicin—sarcoma	0.00226	0.00276	CcSEcCtD
Brinzolamide—Feeling abnormal—Dactinomycin—sarcoma	0.00225	0.00275	CcSEcCtD
Brinzolamide—Ill-defined disorder—Etoposide—sarcoma	0.00225	0.00275	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Vincristine—sarcoma	0.00222	0.00272	CcSEcCtD
Brinzolamide—Hypotension—Mitoxantrone—sarcoma	0.00222	0.00271	CcSEcCtD
Brinzolamide—CA1—lymph node—sarcoma	0.00222	0.0122	CbGeAlD
Brinzolamide—Insomnia—Vincristine—sarcoma	0.00221	0.0027	CcSEcCtD
Brinzolamide—Paraesthesia—Vincristine—sarcoma	0.00219	0.00268	CcSEcCtD
Brinzolamide—Urticaria—Thiotepa—sarcoma	0.00219	0.00267	CcSEcCtD
Brinzolamide—Malaise—Etoposide—sarcoma	0.00219	0.00267	CcSEcCtD
Brinzolamide—Vertigo—Etoposide—sarcoma	0.00218	0.00266	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00217	0.00265	CcSEcCtD
Brinzolamide—Paraesthesia—Mitoxantrone—sarcoma	0.00214	0.00261	CcSEcCtD
Brinzolamide—Decreased appetite—Vincristine—sarcoma	0.00212	0.00259	CcSEcCtD
Brinzolamide—Dyspnoea—Mitoxantrone—sarcoma	0.00212	0.00259	CcSEcCtD
Brinzolamide—Cough—Etoposide—sarcoma	0.00211	0.00258	CcSEcCtD
Brinzolamide—Somnolence—Mitoxantrone—sarcoma	0.00211	0.00258	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Vincristine—sarcoma	0.00211	0.00258	CcSEcCtD
Brinzolamide—Fatigue—Vincristine—sarcoma	0.0021	0.00257	CcSEcCtD
Brinzolamide—Dyspepsia—Mitoxantrone—sarcoma	0.00209	0.00256	CcSEcCtD
Brinzolamide—Hypertension—Etoposide—sarcoma	0.00209	0.00256	CcSEcCtD
Brinzolamide—Pain—Vincristine—sarcoma	0.00209	0.00255	CcSEcCtD
Brinzolamide—Pain in extremity—Doxorubicin—sarcoma	0.00209	0.00255	CcSEcCtD
Brinzolamide—Diplopia—Doxorubicin—sarcoma	0.00209	0.00255	CcSEcCtD
Brinzolamide—Liver function test abnormal—Epirubicin—sarcoma	0.00208	0.00254	CcSEcCtD
Brinzolamide—Decreased appetite—Mitoxantrone—sarcoma	0.00207	0.00253	CcSEcCtD
Brinzolamide—Chest pain—Etoposide—sarcoma	0.00206	0.00252	CcSEcCtD
Brinzolamide—Abdominal pain upper—Epirubicin—sarcoma	0.00206	0.00252	CcSEcCtD
Brinzolamide—Fatigue—Mitoxantrone—sarcoma	0.00205	0.0025	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00205	0.0025	CcSEcCtD
Brinzolamide—Discomfort—Etoposide—sarcoma	0.00204	0.00249	CcSEcCtD
Brinzolamide—Breast disorder—Epirubicin—sarcoma	0.00204	0.00249	CcSEcCtD
Brinzolamide—Pain—Mitoxantrone—sarcoma	0.00203	0.00248	CcSEcCtD
Brinzolamide—Hypersensitivity—Thiotepa—sarcoma	0.00203	0.00248	CcSEcCtD
Brinzolamide—Nasopharyngitis—Epirubicin—sarcoma	0.00202	0.00246	CcSEcCtD
Brinzolamide—Hypersensitivity—Dactinomycin—sarcoma	0.00201	0.00246	CcSEcCtD
Brinzolamide—CA2—testis—sarcoma	0.00198	0.0109	CbGeAlD
Brinzolamide—Asthenia—Thiotepa—sarcoma	0.00198	0.00241	CcSEcCtD
Brinzolamide—Infection—Etoposide—sarcoma	0.00196	0.0024	CcSEcCtD
Brinzolamide—Asthenia—Dactinomycin—sarcoma	0.00196	0.0024	CcSEcCtD
Brinzolamide—Feeling abnormal—Mitoxantrone—sarcoma	0.00196	0.00239	CcSEcCtD
Brinzolamide—Asthma—Epirubicin—sarcoma	0.00195	0.00238	CcSEcCtD
Brinzolamide—Pruritus—Thiotepa—sarcoma	0.00195	0.00238	CcSEcCtD
Brinzolamide—Tachycardia—Etoposide—sarcoma	0.00193	0.00236	CcSEcCtD
Brinzolamide—Liver function test abnormal—Doxorubicin—sarcoma	0.00193	0.00235	CcSEcCtD
Brinzolamide—Skin disorder—Etoposide—sarcoma	0.00192	0.00235	CcSEcCtD
Brinzolamide—Abdominal pain upper—Doxorubicin—sarcoma	0.00191	0.00233	CcSEcCtD
Brinzolamide—Angina pectoris—Epirubicin—sarcoma	0.0019	0.00232	CcSEcCtD
Brinzolamide—Urticaria—Mitoxantrone—sarcoma	0.00189	0.00231	CcSEcCtD
Brinzolamide—Breast disorder—Doxorubicin—sarcoma	0.00189	0.0023	CcSEcCtD
Brinzolamide—Diarrhoea—Thiotepa—sarcoma	0.00188	0.0023	CcSEcCtD
Brinzolamide—Bronchitis—Epirubicin—sarcoma	0.00187	0.00229	CcSEcCtD
Brinzolamide—CA2—liver—sarcoma	0.00187	0.0103	CbGeAlD
Brinzolamide—Diarrhoea—Dactinomycin—sarcoma	0.00187	0.00228	CcSEcCtD
Brinzolamide—Nasopharyngitis—Doxorubicin—sarcoma	0.00187	0.00228	CcSEcCtD
Brinzolamide—Hypotension—Etoposide—sarcoma	0.00185	0.00226	CcSEcCtD
Brinzolamide—Dizziness—Thiotepa—sarcoma	0.00182	0.00222	CcSEcCtD
Brinzolamide—Asthma—Doxorubicin—sarcoma	0.0018	0.0022	CcSEcCtD
Brinzolamide—Pollakiuria—Epirubicin—sarcoma	0.0018	0.0022	CcSEcCtD
Brinzolamide—Hypersensitivity—Vincristine—sarcoma	0.0018	0.0022	CcSEcCtD
Brinzolamide—Paraesthesia—Etoposide—sarcoma	0.00178	0.00217	CcSEcCtD
Brinzolamide—Dyspnoea—Etoposide—sarcoma	0.00176	0.00215	CcSEcCtD
Brinzolamide—Somnolence—Etoposide—sarcoma	0.00176	0.00215	CcSEcCtD
Brinzolamide—Angina pectoris—Doxorubicin—sarcoma	0.00176	0.00215	CcSEcCtD
Brinzolamide—Hypersensitivity—Mitoxantrone—sarcoma	0.00175	0.00214	CcSEcCtD
Brinzolamide—Asthenia—Vincristine—sarcoma	0.00175	0.00214	CcSEcCtD
Brinzolamide—Vomiting—Thiotepa—sarcoma	0.00175	0.00214	CcSEcCtD
Brinzolamide—Infestation NOS—Epirubicin—sarcoma	0.00174	0.00212	CcSEcCtD
Brinzolamide—Infestation—Epirubicin—sarcoma	0.00174	0.00212	CcSEcCtD
Brinzolamide—Vomiting—Dactinomycin—sarcoma	0.00174	0.00212	CcSEcCtD
Brinzolamide—Rash—Thiotepa—sarcoma	0.00174	0.00212	CcSEcCtD
Brinzolamide—Bronchitis—Doxorubicin—sarcoma	0.00173	0.00212	CcSEcCtD
Brinzolamide—Dermatitis—Thiotepa—sarcoma	0.00173	0.00212	CcSEcCtD
Brinzolamide—CA4—lymph node—sarcoma	0.00173	0.00955	CbGeAlD
Brinzolamide—Headache—Thiotepa—sarcoma	0.00172	0.00211	CcSEcCtD
Brinzolamide—Rash—Dactinomycin—sarcoma	0.00172	0.00211	CcSEcCtD
Brinzolamide—Decreased appetite—Etoposide—sarcoma	0.00172	0.0021	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Etoposide—sarcoma	0.00171	0.00209	CcSEcCtD
Brinzolamide—Asthenia—Mitoxantrone—sarcoma	0.00171	0.00208	CcSEcCtD
Brinzolamide—Fatigue—Etoposide—sarcoma	0.00171	0.00208	CcSEcCtD
Brinzolamide—Pain—Etoposide—sarcoma	0.00169	0.00207	CcSEcCtD
Brinzolamide—Conjunctivitis—Epirubicin—sarcoma	0.00169	0.00206	CcSEcCtD
Brinzolamide—Diarrhoea—Vincristine—sarcoma	0.00167	0.00204	CcSEcCtD
Brinzolamide—Pollakiuria—Doxorubicin—sarcoma	0.00167	0.00204	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Epirubicin—sarcoma	0.00164	0.00201	CcSEcCtD
Brinzolamide—Epistaxis—Epirubicin—sarcoma	0.00164	0.002	CcSEcCtD
Brinzolamide—Nausea—Thiotepa—sarcoma	0.00164	0.002	CcSEcCtD
Brinzolamide—Sinusitis—Epirubicin—sarcoma	0.00163	0.00199	CcSEcCtD
Brinzolamide—Feeling abnormal—Etoposide—sarcoma	0.00163	0.00199	CcSEcCtD
Brinzolamide—Diarrhoea—Mitoxantrone—sarcoma	0.00163	0.00199	CcSEcCtD
Brinzolamide—Nausea—Dactinomycin—sarcoma	0.00162	0.00198	CcSEcCtD
Brinzolamide—Dizziness—Vincristine—sarcoma	0.00161	0.00197	CcSEcCtD
Brinzolamide—Infestation NOS—Doxorubicin—sarcoma	0.00161	0.00197	CcSEcCtD
Brinzolamide—Infestation—Doxorubicin—sarcoma	0.00161	0.00197	CcSEcCtD
Brinzolamide—Bradycardia—Epirubicin—sarcoma	0.00159	0.00194	CcSEcCtD
Brinzolamide—Urticaria—Etoposide—sarcoma	0.00157	0.00192	CcSEcCtD
Brinzolamide—Rhinitis—Epirubicin—sarcoma	0.00156	0.00191	CcSEcCtD
Brinzolamide—Conjunctivitis—Doxorubicin—sarcoma	0.00156	0.00191	CcSEcCtD
Brinzolamide—Hypoaesthesia—Epirubicin—sarcoma	0.00155	0.0019	CcSEcCtD
Brinzolamide—Vomiting—Vincristine—sarcoma	0.00155	0.0019	CcSEcCtD
Brinzolamide—Pharyngitis—Epirubicin—sarcoma	0.00155	0.00189	CcSEcCtD
Brinzolamide—Urinary tract disorder—Epirubicin—sarcoma	0.00154	0.00188	CcSEcCtD
Brinzolamide—Rash—Vincristine—sarcoma	0.00154	0.00188	CcSEcCtD
Brinzolamide—Dermatitis—Vincristine—sarcoma	0.00154	0.00188	CcSEcCtD
Brinzolamide—Oedema peripheral—Epirubicin—sarcoma	0.00154	0.00188	CcSEcCtD
Brinzolamide—Connective tissue disorder—Epirubicin—sarcoma	0.00153	0.00187	CcSEcCtD
Brinzolamide—Urethral disorder—Epirubicin—sarcoma	0.00153	0.00187	CcSEcCtD
Brinzolamide—Headache—Vincristine—sarcoma	0.00153	0.00187	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Doxorubicin—sarcoma	0.00152	0.00186	CcSEcCtD
Brinzolamide—Epistaxis—Doxorubicin—sarcoma	0.00152	0.00185	CcSEcCtD
Brinzolamide—Vomiting—Mitoxantrone—sarcoma	0.00151	0.00185	CcSEcCtD
Brinzolamide—Sinusitis—Doxorubicin—sarcoma	0.00151	0.00184	CcSEcCtD
Brinzolamide—Visual impairment—Epirubicin—sarcoma	0.0015	0.00184	CcSEcCtD
Brinzolamide—Rash—Mitoxantrone—sarcoma	0.0015	0.00183	CcSEcCtD
Brinzolamide—Dermatitis—Mitoxantrone—sarcoma	0.0015	0.00183	CcSEcCtD
Brinzolamide—Headache—Mitoxantrone—sarcoma	0.00149	0.00182	CcSEcCtD
Brinzolamide—Bradycardia—Doxorubicin—sarcoma	0.00147	0.0018	CcSEcCtD
Brinzolamide—Eye disorder—Epirubicin—sarcoma	0.00146	0.00178	CcSEcCtD
Brinzolamide—Hypersensitivity—Etoposide—sarcoma	0.00146	0.00178	CcSEcCtD
Brinzolamide—Tinnitus—Epirubicin—sarcoma	0.00145	0.00178	CcSEcCtD
Brinzolamide—Nausea—Vincristine—sarcoma	0.00145	0.00177	CcSEcCtD
Brinzolamide—Cardiac disorder—Epirubicin—sarcoma	0.00145	0.00177	CcSEcCtD
Brinzolamide—Rhinitis—Doxorubicin—sarcoma	0.00145	0.00177	CcSEcCtD
Brinzolamide—CA2—lymph node—sarcoma	0.00144	0.00792	CbGeAlD
Brinzolamide—Hypoaesthesia—Doxorubicin—sarcoma	0.00144	0.00176	CcSEcCtD
Brinzolamide—Pharyngitis—Doxorubicin—sarcoma	0.00143	0.00175	CcSEcCtD
Brinzolamide—Urinary tract disorder—Doxorubicin—sarcoma	0.00143	0.00174	CcSEcCtD
Brinzolamide—Oedema peripheral—Doxorubicin—sarcoma	0.00142	0.00174	CcSEcCtD
Brinzolamide—Asthenia—Etoposide—sarcoma	0.00142	0.00173	CcSEcCtD
Brinzolamide—Connective tissue disorder—Doxorubicin—sarcoma	0.00142	0.00173	CcSEcCtD
Brinzolamide—Angiopathy—Epirubicin—sarcoma	0.00142	0.00173	CcSEcCtD
Brinzolamide—Urethral disorder—Doxorubicin—sarcoma	0.00142	0.00173	CcSEcCtD
Brinzolamide—Nausea—Mitoxantrone—sarcoma	0.00141	0.00173	CcSEcCtD
Brinzolamide—Immune system disorder—Epirubicin—sarcoma	0.00141	0.00172	CcSEcCtD
Brinzolamide—Mediastinal disorder—Epirubicin—sarcoma	0.00141	0.00172	CcSEcCtD
Brinzolamide—Pruritus—Etoposide—sarcoma	0.0014	0.00171	CcSEcCtD
Brinzolamide—Arrhythmia—Epirubicin—sarcoma	0.00139	0.0017	CcSEcCtD
Brinzolamide—Visual impairment—Doxorubicin—sarcoma	0.00139	0.0017	CcSEcCtD
Brinzolamide—Alopecia—Epirubicin—sarcoma	0.00138	0.00168	CcSEcCtD
Brinzolamide—Mental disorder—Epirubicin—sarcoma	0.00137	0.00167	CcSEcCtD
Brinzolamide—Erythema—Epirubicin—sarcoma	0.00136	0.00166	CcSEcCtD
Brinzolamide—Malnutrition—Epirubicin—sarcoma	0.00136	0.00166	CcSEcCtD
Brinzolamide—Diarrhoea—Etoposide—sarcoma	0.00135	0.00165	CcSEcCtD
Brinzolamide—Eye disorder—Doxorubicin—sarcoma	0.00135	0.00165	CcSEcCtD
Brinzolamide—Tinnitus—Doxorubicin—sarcoma	0.00135	0.00164	CcSEcCtD
Brinzolamide—Cardiac disorder—Doxorubicin—sarcoma	0.00134	0.00164	CcSEcCtD
Brinzolamide—Flatulence—Epirubicin—sarcoma	0.00134	0.00164	CcSEcCtD
Brinzolamide—Tension—Epirubicin—sarcoma	0.00133	0.00163	CcSEcCtD
Brinzolamide—Dysgeusia—Epirubicin—sarcoma	0.00133	0.00163	CcSEcCtD
Brinzolamide—Nervousness—Epirubicin—sarcoma	0.00132	0.00161	CcSEcCtD
Brinzolamide—Back pain—Epirubicin—sarcoma	0.00131	0.00161	CcSEcCtD
Brinzolamide—Angiopathy—Doxorubicin—sarcoma	0.00131	0.0016	CcSEcCtD
Brinzolamide—Dizziness—Etoposide—sarcoma	0.00131	0.0016	CcSEcCtD
Brinzolamide—Muscle spasms—Epirubicin—sarcoma	0.00131	0.0016	CcSEcCtD
Brinzolamide—Immune system disorder—Doxorubicin—sarcoma	0.0013	0.00159	CcSEcCtD
Brinzolamide—Mediastinal disorder—Doxorubicin—sarcoma	0.0013	0.00159	CcSEcCtD
Brinzolamide—Arrhythmia—Doxorubicin—sarcoma	0.00129	0.00158	CcSEcCtD
Brinzolamide—Vision blurred—Epirubicin—sarcoma	0.00128	0.00156	CcSEcCtD
Brinzolamide—Alopecia—Doxorubicin—sarcoma	0.00128	0.00156	CcSEcCtD
Brinzolamide—Mental disorder—Doxorubicin—sarcoma	0.00126	0.00155	CcSEcCtD
Brinzolamide—Ill-defined disorder—Epirubicin—sarcoma	0.00126	0.00154	CcSEcCtD
Brinzolamide—Vomiting—Etoposide—sarcoma	0.00126	0.00154	CcSEcCtD
Brinzolamide—Malnutrition—Doxorubicin—sarcoma	0.00126	0.00154	CcSEcCtD
Brinzolamide—Erythema—Doxorubicin—sarcoma	0.00126	0.00154	CcSEcCtD
Brinzolamide—Agitation—Epirubicin—sarcoma	0.00125	0.00153	CcSEcCtD
Brinzolamide—Rash—Etoposide—sarcoma	0.00125	0.00152	CcSEcCtD
Brinzolamide—Dermatitis—Etoposide—sarcoma	0.00125	0.00152	CcSEcCtD
Brinzolamide—Headache—Etoposide—sarcoma	0.00124	0.00151	CcSEcCtD
Brinzolamide—Flatulence—Doxorubicin—sarcoma	0.00124	0.00151	CcSEcCtD
Brinzolamide—Tension—Doxorubicin—sarcoma	0.00123	0.00151	CcSEcCtD
Brinzolamide—Dysgeusia—Doxorubicin—sarcoma	0.00123	0.0015	CcSEcCtD
Brinzolamide—Malaise—Epirubicin—sarcoma	0.00122	0.0015	CcSEcCtD
Brinzolamide—Nervousness—Doxorubicin—sarcoma	0.00122	0.00149	CcSEcCtD
Brinzolamide—Vertigo—Epirubicin—sarcoma	0.00122	0.00149	CcSEcCtD
Brinzolamide—Back pain—Doxorubicin—sarcoma	0.00122	0.00149	CcSEcCtD
Brinzolamide—CYP3A4—liver—sarcoma	0.00121	0.00666	CbGeAlD
Brinzolamide—Muscle spasms—Doxorubicin—sarcoma	0.00121	0.00148	CcSEcCtD
Brinzolamide—Palpitations—Epirubicin—sarcoma	0.0012	0.00147	CcSEcCtD
Brinzolamide—Cough—Epirubicin—sarcoma	0.00119	0.00145	CcSEcCtD
Brinzolamide—Vision blurred—Doxorubicin—sarcoma	0.00118	0.00145	CcSEcCtD
Brinzolamide—Nausea—Etoposide—sarcoma	0.00117	0.00144	CcSEcCtD
Brinzolamide—Hypertension—Epirubicin—sarcoma	0.00117	0.00143	CcSEcCtD
Brinzolamide—Ill-defined disorder—Doxorubicin—sarcoma	0.00117	0.00142	CcSEcCtD
Brinzolamide—Chest pain—Epirubicin—sarcoma	0.00116	0.00141	CcSEcCtD
Brinzolamide—Myalgia—Epirubicin—sarcoma	0.00116	0.00141	CcSEcCtD
Brinzolamide—Arthralgia—Epirubicin—sarcoma	0.00116	0.00141	CcSEcCtD
Brinzolamide—Agitation—Doxorubicin—sarcoma	0.00116	0.00141	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00115	0.0014	CcSEcCtD
Brinzolamide—Discomfort—Epirubicin—sarcoma	0.00114	0.0014	CcSEcCtD
Brinzolamide—Malaise—Doxorubicin—sarcoma	0.00113	0.00138	CcSEcCtD
Brinzolamide—Dry mouth—Epirubicin—sarcoma	0.00113	0.00138	CcSEcCtD
Brinzolamide—Vertigo—Doxorubicin—sarcoma	0.00113	0.00138	CcSEcCtD
Brinzolamide—Palpitations—Doxorubicin—sarcoma	0.00111	0.00136	CcSEcCtD
Brinzolamide—Infection—Epirubicin—sarcoma	0.0011	0.00135	CcSEcCtD
Brinzolamide—Cough—Doxorubicin—sarcoma	0.0011	0.00134	CcSEcCtD
Brinzolamide—Nervous system disorder—Epirubicin—sarcoma	0.00109	0.00133	CcSEcCtD
Brinzolamide—Hypertension—Doxorubicin—sarcoma	0.00109	0.00133	CcSEcCtD
Brinzolamide—Tachycardia—Epirubicin—sarcoma	0.00108	0.00132	CcSEcCtD
Brinzolamide—Skin disorder—Epirubicin—sarcoma	0.00108	0.00132	CcSEcCtD
Brinzolamide—Myalgia—Doxorubicin—sarcoma	0.00107	0.00131	CcSEcCtD
Brinzolamide—Chest pain—Doxorubicin—sarcoma	0.00107	0.00131	CcSEcCtD
Brinzolamide—Arthralgia—Doxorubicin—sarcoma	0.00107	0.00131	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00106	0.0013	CcSEcCtD
Brinzolamide—Discomfort—Doxorubicin—sarcoma	0.00106	0.00129	CcSEcCtD
Brinzolamide—Dry mouth—Doxorubicin—sarcoma	0.00105	0.00128	CcSEcCtD
Brinzolamide—Hypotension—Epirubicin—sarcoma	0.00104	0.00127	CcSEcCtD
Brinzolamide—Infection—Doxorubicin—sarcoma	0.00102	0.00125	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00101	0.00123	CcSEcCtD
Brinzolamide—Nervous system disorder—Doxorubicin—sarcoma	0.00101	0.00123	CcSEcCtD
Brinzolamide—Insomnia—Epirubicin—sarcoma	0.001	0.00123	CcSEcCtD
Brinzolamide—Tachycardia—Doxorubicin—sarcoma	0.001	0.00122	CcSEcCtD
Brinzolamide—Skin disorder—Doxorubicin—sarcoma	0.000996	0.00122	CcSEcCtD
Brinzolamide—Paraesthesia—Epirubicin—sarcoma	0.000995	0.00122	CcSEcCtD
Brinzolamide—Dyspnoea—Epirubicin—sarcoma	0.000988	0.00121	CcSEcCtD
Brinzolamide—Somnolence—Epirubicin—sarcoma	0.000986	0.0012	CcSEcCtD
Brinzolamide—Dyspepsia—Epirubicin—sarcoma	0.000976	0.00119	CcSEcCtD
Brinzolamide—Decreased appetite—Epirubicin—sarcoma	0.000964	0.00118	CcSEcCtD
Brinzolamide—Hypotension—Doxorubicin—sarcoma	0.000959	0.00117	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000957	0.00117	CcSEcCtD
Brinzolamide—Fatigue—Epirubicin—sarcoma	0.000956	0.00117	CcSEcCtD
Brinzolamide—Pain—Epirubicin—sarcoma	0.000948	0.00116	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000935	0.00114	CcSEcCtD
Brinzolamide—Insomnia—Doxorubicin—sarcoma	0.000928	0.00113	CcSEcCtD
Brinzolamide—Paraesthesia—Doxorubicin—sarcoma	0.000921	0.00113	CcSEcCtD
Brinzolamide—Dyspnoea—Doxorubicin—sarcoma	0.000915	0.00112	CcSEcCtD
Brinzolamide—Feeling abnormal—Epirubicin—sarcoma	0.000914	0.00112	CcSEcCtD
Brinzolamide—Somnolence—Doxorubicin—sarcoma	0.000912	0.00111	CcSEcCtD
Brinzolamide—Dyspepsia—Doxorubicin—sarcoma	0.000903	0.0011	CcSEcCtD
Brinzolamide—Decreased appetite—Doxorubicin—sarcoma	0.000892	0.00109	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000886	0.00108	CcSEcCtD
Brinzolamide—Fatigue—Doxorubicin—sarcoma	0.000884	0.00108	CcSEcCtD
Brinzolamide—Urticaria—Epirubicin—sarcoma	0.000881	0.00108	CcSEcCtD
Brinzolamide—Pain—Doxorubicin—sarcoma	0.000877	0.00107	CcSEcCtD
Brinzolamide—Feeling abnormal—Doxorubicin—sarcoma	0.000845	0.00103	CcSEcCtD
Brinzolamide—Hypersensitivity—Epirubicin—sarcoma	0.000817	0.000998	CcSEcCtD
Brinzolamide—Urticaria—Doxorubicin—sarcoma	0.000815	0.000996	CcSEcCtD
Brinzolamide—Asthenia—Epirubicin—sarcoma	0.000795	0.000972	CcSEcCtD
Brinzolamide—Pruritus—Epirubicin—sarcoma	0.000784	0.000958	CcSEcCtD
Brinzolamide—Diarrhoea—Epirubicin—sarcoma	0.000759	0.000927	CcSEcCtD
Brinzolamide—Hypersensitivity—Doxorubicin—sarcoma	0.000756	0.000923	CcSEcCtD
Brinzolamide—Asthenia—Doxorubicin—sarcoma	0.000736	0.000899	CcSEcCtD
Brinzolamide—Dizziness—Epirubicin—sarcoma	0.000733	0.000896	CcSEcCtD
Brinzolamide—Pruritus—Doxorubicin—sarcoma	0.000726	0.000887	CcSEcCtD
Brinzolamide—Vomiting—Epirubicin—sarcoma	0.000705	0.000861	CcSEcCtD
Brinzolamide—Diarrhoea—Doxorubicin—sarcoma	0.000702	0.000857	CcSEcCtD
Brinzolamide—Rash—Epirubicin—sarcoma	0.000699	0.000854	CcSEcCtD
Brinzolamide—Dermatitis—Epirubicin—sarcoma	0.000698	0.000853	CcSEcCtD
Brinzolamide—Headache—Epirubicin—sarcoma	0.000695	0.000849	CcSEcCtD
Brinzolamide—Dizziness—Doxorubicin—sarcoma	0.000678	0.000829	CcSEcCtD
Brinzolamide—Nausea—Epirubicin—sarcoma	0.000659	0.000805	CcSEcCtD
Brinzolamide—Vomiting—Doxorubicin—sarcoma	0.000652	0.000797	CcSEcCtD
Brinzolamide—Rash—Doxorubicin—sarcoma	0.000647	0.00079	CcSEcCtD
Brinzolamide—Dermatitis—Doxorubicin—sarcoma	0.000646	0.000789	CcSEcCtD
Brinzolamide—Headache—Doxorubicin—sarcoma	0.000643	0.000785	CcSEcCtD
Brinzolamide—Nausea—Doxorubicin—sarcoma	0.000609	0.000744	CcSEcCtD
